PRIDE III Prison Interventions and HIV Prevention Collaboration

The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).

NCT Number	NCT06962033
Lead Sponsor	Yale University Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Hiv, Opioid Use
Enrollment	300 participants
Start Date	2024-11-05
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2025-05-11